The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia
Identifieur interne : 001198 ( Istex/Curation ); précédent : 001197; suivant : 001199The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia
Auteurs : Sudeep S. Gill [Canada] ; Paula A. Rochon [Canada] ; Mark Guttman [Canada] ; Andreas LaupacisSource :
- Journal of the American Geriatrics Society [ 0002-8614 ] ; 2003-02.
English descriptors
Abstract
Positron emission tomography (PET) has been promoted as a means of improving the diagnosis of Alzheimer's disease (AD), but the evidence to support its incremental value is unclear. To assess the evidence regarding the use of PET in the clinical evaluation of AD, a systematic review of the English‐language literature indexed in MEDLINE (1975–January 2001), the Cochrane Library (issue 4, 2000), and health technology assessment (HTA) reports was conducted. Articles identified by this review process were graded for methodological and reporting quality using a standardized grading scheme. Sixteen original articles and seven HTA reports were identified. In general, the articles addressed: using PET to differentiate AD from normal aging or non‐Alzheimer's dementias, PET imaging compared with single positron emission computed tomography imaging, using PET to predict the progression of dementia, and agreement and reliability in the interpretation of PET images. Serious problems with study design and methodology in all articles were identified. Previous HTA reports have generally recommended that PET not be used in the clinical evaluation of dementia. In conclusion, there is little evidence to support the addition of PET to the routine clinical evaluation of patients with suspected or established dementia. Suggestions for future research in this area are offered.
Url:
DOI: 10.1046/j.1532-5415.2003.51067.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001198
Links to Exploration step
ISTEX:5AB0A6DAF19EB09262E91B65EF9FCEF2DB17B13DCuration
No country items
Andreas Laupacis<affiliation><mods:affiliation>Department of Medicine,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation>Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia</title><author><name sortKey="Gill, Sudeep S" sort="Gill, Sudeep S" uniqKey="Gill S" first="Sudeep S." last="Gill">Sudeep S. Gill</name><affiliation wicri:level="1"><mods:affiliation>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto, Canada;</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Rochon, Paula A" sort="Rochon, Paula A" uniqKey="Rochon P" first="Paula A." last="Rochon">Paula A. Rochon</name><affiliation wicri:level="1"><mods:affiliation>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto, Canada;</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto</wicri:regionArea></affiliation><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation><affiliation><mods:affiliation>Public Health Sciences,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation><affiliation><mods:affiliation>Division of Neurology, and</mods:affiliation><wicri:noCountry code="subField">and</wicri:noCountry></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Psychiatry, National Parkinson Foundation Center of Excellence, University of Toronto, Toronto, Canada; and</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Department of Psychiatry, National Parkinson Foundation Center of Excellence, University of Toronto, Toronto</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Center forAddiction and Mental Health, Toronto, Canada.</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Center forAddiction and Mental Health, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Laupacis, Andreas" sort="Laupacis, Andreas" uniqKey="Laupacis A" first="Andreas" last="Laupacis">Andreas Laupacis</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5AB0A6DAF19EB09262E91B65EF9FCEF2DB17B13D</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1046/j.1532-5415.2003.51067.x</idno><idno type="url">https://api-v5.istex.fr/document/5AB0A6DAF19EB09262E91B65EF9FCEF2DB17B13D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001198</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001198</idno><idno type="wicri:Area/Istex/Curation">001198</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia</title><author><name sortKey="Gill, Sudeep S" sort="Gill, Sudeep S" uniqKey="Gill S" first="Sudeep S." last="Gill">Sudeep S. Gill</name><affiliation wicri:level="1"><mods:affiliation>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto, Canada;</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Rochon, Paula A" sort="Rochon, Paula A" uniqKey="Rochon P" first="Paula A." last="Rochon">Paula A. Rochon</name><affiliation wicri:level="1"><mods:affiliation>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto, Canada;</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Kunin‐Lunenfeld Applied Research Unit, Baycrest Center forGeriatric Care, Toronto</wicri:regionArea></affiliation><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences,</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation></affiliation><affiliation><mods:affiliation>Public Health Sciences,</mods:affiliation></affiliation></author><author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation></affiliation><affiliation><mods:affiliation>Division of Neurology, and</mods:affiliation></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Psychiatry, National Parkinson Foundation Center of Excellence, University of Toronto, Toronto, Canada; and</mods:affiliation><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>Department of Psychiatry, National Parkinson Foundation Center of Excellence, University of Toronto, Toronto</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Center forAddiction and Mental Health, Toronto, Canada.</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Center forAddiction and Mental Health, Toronto</wicri:regionArea></affiliation></author><author><name sortKey="Laupacis, Andreas" sort="Laupacis, Andreas" uniqKey="Laupacis A" first="Andreas" last="Laupacis">Andreas Laupacis</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences,</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Medicine,</mods:affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the American Geriatrics Society</title><title level="j" type="abbrev">Journal of the American Geriatrics Society</title><idno type="ISSN">0002-8614</idno><idno type="eISSN">1532-5415</idno><imprint><publisher>Blackwell Science Inc</publisher><pubPlace>Boston, MA, USA</pubPlace><date type="published" when="2003-02">2003-02</date><biblScope unit="volume">51</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="258">258</biblScope><biblScope unit="page" to="264">264</biblScope></imprint><idno type="ISSN">0002-8614</idno></series><idno type="istex">5AB0A6DAF19EB09262E91B65EF9FCEF2DB17B13D</idno><idno type="DOI">10.1046/j.1532-5415.2003.51067.x</idno><idno type="ArticleID">jgs51067</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-8614</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer's disease</term><term>dementia</term><term>positron emission tomography</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Positron emission tomography (PET) has been promoted as a means of improving the diagnosis of Alzheimer's disease (AD), but the evidence to support its incremental value is unclear. To assess the evidence regarding the use of PET in the clinical evaluation of AD, a systematic review of the English‐language literature indexed in MEDLINE (1975–January 2001), the Cochrane Library (issue 4, 2000), and health technology assessment (HTA) reports was conducted. Articles identified by this review process were graded for methodological and reporting quality using a standardized grading scheme. Sixteen original articles and seven HTA reports were identified. In general, the articles addressed: using PET to differentiate AD from normal aging or non‐Alzheimer's dementias, PET imaging compared with single positron emission computed tomography imaging, using PET to predict the progression of dementia, and agreement and reliability in the interpretation of PET images. Serious problems with study design and methodology in all articles were identified. Previous HTA reports have generally recommended that PET not be used in the clinical evaluation of dementia. In conclusion, there is little evidence to support the addition of PET to the routine clinical evaluation of patients with suspected or established dementia. Suggestions for future research in this area are offered.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001198 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001198 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:5AB0A6DAF19EB09262E91B65EF9FCEF2DB17B13D
|texte= The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia
}}
| This area was generated with Dilib version V0.6.29. |  |